New MenB vaccine heralds use of genetic vaccines to combat bacterial diseases

by

A vaccine candidate that can protect children from Meningococcal group B (MenB), which can lead to meningitis, has progressed to clinical development, according to an announcement by researchers from the University of Surrey and the University of Oxford.

Leave A Comment

Your email address will not be published. Required fields are marked *